Merck KGaA Investor Presentation — January 2020

Document content

Frankfurt - January 20 , 2020MeRc k

19th German Corporate

Conference Unicredit

KeplerChevreuxDisclaimer

Cautionary Note Regarding Forward -Looking Statements andfinancial indicators

Thiscommunication may include “forward -looking statements .”Statements thatinclude words such as“anticipate,” “expect,” “should,” “would,” “intend,” “plan,” “project,” “seek,”

“believe,” “will,” andother words ofsimilar meaning inconnection withfuture events orfuture operating orfinancial performance areoften used toidentify forward -looking statements .

Allstatements inthiscommunication, other than those relating tohistorical information orcurrent conditions, areforward -looking statements .Weintend these forward -looking

statements tobecovered bythesafeharbor provisions forforward -looking statements inthePrivate Securities Litigation Reform Actof1995.These forward -looking statements are

subject toanumber ofrisks anduncertainties, many ofwhich arebeyond control ofMerck KGaA ,Darmstadt, Germany, which could cause actual results todiffer materially from such

Risks anduncertainties include, butarenotlimited to:therisks ofmore restrictive regulatory requirements regarding drug pricing, reimbursement andapproval ;theriskofstricter

regulations forthemanufacture, testing andmarketing ofproducts ;theriskofdestabilization ofpolitical systems andtheestablishment oftrade barriers ;theriskofachanging

marketing environment formultiple sclerosis products intheEuropean Union ;theriskofgreater competitive pressure duetobiosimilars ;therisks ofresearch anddevelopment ;the

risks ofdiscontinuing development projects andregulatory approval ofdeveloped medicines ;theriskofatemporary banonproducts/production facilities orofnon-registration of